tranylcypromine has been researched along with nomifensine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Nolen, WA | 1 |
| Delini-Stula, A; Heath, WR; Schiwy, W | 1 |
| Dubicki, W; Goudie, AJ; Leathley, M | 1 |
| Smith, DF | 1 |
| Blansjaar, BA; Dijken, WA; Haffmans, J; Kamp, JS; Kramer, HJ; Nolen, WA; van de Putte, JJ | 1 |
| Matsubara, K; Matsushita, A | 1 |
| Grünberger, L; Linzmayer, L; Saletu, B; Stöhr, H; Wittek, R | 1 |
| Cheetham, SC; Heal, DJ; Martin, KF; Phillips, I | 1 |
4 trial(s) available for tranylcypromine and nomifensine
| Article | Year |
|---|---|
Tranylcypromine in depression resistant to cyclic antidepressions.
Topics: 5-Hydroxytryptophan; Adult; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nomifensine; Tranylcypromine | 1989 |
Therapeutic and side-effect profile of a selective and reversible MAO-A inhibitor, brofaromine. Results of dose-finding trials in depressed patients.
Topics: Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Nomifensine; Piperidines; Psychiatric Status Rating Scales; Random Allocation; Tranylcypromine | 1989 |
Treatment strategy in depression. II. MAO inhibitors in depression resistant to cyclic antidepressants: two controlled crossover studies with tranylcypromine versus L-5-hydroxytryptophan and nomifensine.
Topics: 5-Hydroxytryptophan; Adult; Aged; Clinical Trials as Topic; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Resistance; Female; Fluvoxamine; Humans; Male; Maprotiline; Middle Aged; Nomifensine; Oximes; Psychological Tests; Tranylcypromine | 1988 |
[Classification and determination of the pharmacodynamics of a new tetracyclic antidepressive agent, pirlindol, using pharmaco-EEG and psychometry].
Topics: Adult; Antidepressive Agents; Arousal; Carbazoles; Clinical Trials as Topic; Electroencephalography; Female; Flicker Fusion; Heart Function Tests; Humans; Imipramine; Male; Nomifensine; Placebos; Psychometrics; Psychopharmacology; Reaction Time; Reference Values; Tranylcypromine | 1983 |
5 other study(ies) available for tranylcypromine and nomifensine
| Article | Year |
|---|---|
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Paroxetine, a selective 5-hydroxytryptamine uptake inhibitor with antidepressant properties, lacks amphetamine-like stimulus properties in an operant drug discrimination bioassay in rodents.
Topics: Animals; Antidepressive Agents; Conditioning, Operant; Dextroamphetamine; Discrimination Learning; Discrimination, Psychological; Female; Flicker Fusion; Nomifensine; Paroxetine; Piperidines; Psychomotor Performance; Rats; Serotonin Antagonists; Tranylcypromine | 1988 |
The stereoselectivity of serotonin uptake in brain tissue and blood platelets: the topography of the serotonin uptake area.
Topics: Alanine; Amphetamine; Aniline Compounds; Animals; Antidepressive Agents; Blood Platelets; Brain; Fluoxetine; Humans; Male; Methadone; Mianserin; Mirtazapine; Morpholines; Naphthalenes; Nefopam; Nomifensine; Paroxetine; Piperidines; Rabbits; Serotonin; Stereoisomerism; Tranylcypromine; Viloxazine; Zimeldine | 1986 |
Analysis of the long-lasting antagonistic effect of caerulein on amphetamine hyperactivity in rats.
Topics: Amphetamine; Animals; Apomorphine; Ceruletide; Haloperidol; Male; Motor Activity; Nomifensine; Rats; Rats, Inbred Strains; Time Factors; Tranylcypromine | 1985 |
Dopamine D2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments.
Topics: Animals; Antidepressive Agents; Binding, Competitive; Dopamine Antagonists; Electroconvulsive Therapy; Haloperidol; In Vitro Techniques; Male; Membranes; Neostriatum; Nomifensine; Raclopride; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Salicylamides; Tranylcypromine | 1995 |